UroGen Pharma Ltd. (URGN) Capital expenditures 2016–2025
UroGen Pharma Ltd. (URGN) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$289,000FY2025 · since FY2016: $695,000 → $289,000
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $289,000 | -2.0% |
| FY2024 | $295,000 | +52.1% |
| FY2023 | $194,000 | -23.6% |
| FY2022 | $254,000 | -66.2% |
| FY2021 | $752,000 | -38.1% |
| FY2020 | $1.2M | +273.8% |
| FY2019 | $325,000 | -42.0% |
| FY2018 | $560,000 | +106.6% |
| FY2017 | $271,000 | -61.0% |
| FY2016 | $695,000 | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice